Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes...

10
Diabetic Nephropathy Rick Allen

Transcript of Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes...

Page 1: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Diabetic NephropathyRick Allen

Page 2: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Definition• a glomerulonephropathy is defined by

characteristic structural and functional changes

• Structural: mesangial expansion, GBM thickening and glomelular sclerosis.

• Functional: hyperfiltration and albuminuria.

Page 3: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Epidemiology• DM type I – 20-30% develop microalbuminuria

after 15 years. <1/2 of these overt nephropathy. Can regress or remain stable. Now dropping due to effective control methods.

• DM type II – As above? Rates on the rise due to increased fatty numbers.

• Leading cause of premature death in young diabetics. Second to MI overall.

Page 4: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Risk Factors• Type I = Type II (we think. Start time dubious)• GENETICS (AT2, ACE)• HTN• High GFR• Poor hyperglycaemic control (high HbA1c)• Obesity • Smoking• OCP• Race (blacks 3-6x > whites)…SES? + above.

• Age…unknown, however DM I Dx <5y.o. is good

Page 5: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Ix• earliest detectable sign is microalbuminuria.

• Macroalbominuria is more predictive for future developmet of severe nephropathy and decreased GFR.

Page 6: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Pathophysiology and Pathology• Glomerular sclerosis/damage• Metabolic defect; insulin deficiency hyperglycaemia

biochemical alterations in GBM (increased collagen type IV and fibronectin, decreased proteoglycan) and increased ROS ( damage)

• Nonenzymatic glycosylation inflammatory cytokines and GF released from macrophages, ROs generation in endothelial cells, increased procoagulant activity in endothelial cells and macrophages, ECM synthesis and SM prolif.

• Haemodynamic changes increased GFR, glomerular capillary pressure, glomerular filtration area, and glomerular hypertrophy. • Afferent arteriole is damaged bigger afferent than

efferent increased GFR and pressure, causing further damage and increased shearing forces mesangial cell hypertrophy and excretion of ECM products glomerular sclerosis

Page 7: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Pathophysiology and Pathology 2• Ischaemia (due to hypertrophy of afferent and efferent

arterioles) • hypertrophy and hylanization of vessels ischaemic

kidney damage• Ascending infection• Occur more in women with diabetes than without. No

difference for men. Causes: bladder stasis (neuropathy), infections like to live in damaged kidney (easier to get established)

Page 8: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Pathophysiology and Pathology 3• Under the microscope we get • Glomerular lesions: GBM thickening, diffuse mesangial

sclerosis (PAS positive for stain) and nodular glomerulosclerosis (Kimmelstiel-Wilson lesion, + hyaline accumulations in fibrin caps [in capillary loops] and capsular drops [adhere to Bowman’s capsule]. 15-30% of long term diabetics get this, most associated with renal failure.)

• Vascular lesions: arteriosclerosis/hylanisation of afferent and efferent arterioles

• Pyelonephritis, including necrotising papillitis.• Glomerular and vascular lesions ischaemia tubular

atrophy and interstitial fibrosis overall contraction in size.

Page 9: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

Tx and management• Same as any other chronic renal disease, however;• Use an ACEI or AT2 inhibitor to get that BP down!• Avoid oral hypoglycaemics excreted by the kidney

(metformin)• Assess insulin dose and effectiveness• Retinopathy may cause issues with treatment (blind,

can’t see what doing)• Haemodialysis may be difficult as fistulas calcify

rapidly. Peritoneal. • Kidney transplant failure is higher than pt. without DM.

Page 10: Rick Allen. a glomerulonephropathy is defined by characteristic structural and functional changes Structural: mesangial expansion, GBM thickening and.

The End!